Selma Ugurel (S Ugurel)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Ejection Fraction

Squamous Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

American journal of clinical dermatology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Stang, Lennart Möller, Ina Wellmann, Kevin Claassen, Hiltraud Kajüter, Selma Ugurel, Jürgen Christian Becker
Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008-2021. Cancers 16 (11) (2024)
Lena Espelage, Natalie Wagner, Jan-Malte Placke, Selma Ugurel, Alpaslan Tasdogan
The Interplay between Metabolic Adaptations and Diet in Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jürgen Christian Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. American journal of clinical dermatology 25 (4) (2024)
Jürgen Christian Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. American journal of clinical dermatology 25 (4) (2024)
Jürgen Christian Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. American journal of clinical dermatology 25 (4) (2024)
Jürgen Christian Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. American journal of clinical dermatology (2024)
Jürgen Christian Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. American journal of clinical dermatology 25 (4) (2024)
Jürgen Christian Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. American journal of clinical dermatology 25 (4) (2024)
Lena Espelage, Natalie Wagner, Jan-Malte Placke, Selma Ugurel, Alpaslan Tasdogan
The interplay between metabolic adaptations and diet in cancer immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Andreas Stang, Lennart Möller, Ina Wellmann, Kevin Claassen, Hiltraud Kajüter, Selma Ugurel, Jürgen Christian Becker
Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008-2021. Cancers 16 (11) (2024)
Maximilian Haist, Henner Stege, Friederike Rogall, Yuqi Tan, Imke von Wasielewski, Kai Christian Klespe, Friedegund Meier, Peter Mohr, Katharina C Kähler, Michael Weichenthal, Axel Hauschild, Dirk Schadendorf, Selma Ugurel, Georg Lodde, Lisa Zimmer, Ralf Gutzmer, Dirk Debus, Bastian Schilling, Alexander Kreuter, Jens Ulrich, Frank Meiss, Rudolf Herbst, Andrea Forschner, Ulrike Leiter, Claudia Pfoehler, Martin Kaatz, Fabian Ziller, Jessica C Hassel, Michael Tronnier, Michael Sachse, Edgar Dippel, Patrick Terheyden, Carola Berking, Markus V Heppt, Felix Kiecker, Sebastian Haferkamp, Christoffer Gebhardt, Jan Christoph Simon, Stephan Grabbe, Carmen Loquai
Treatment management for BRAF -mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 11 (9) (2023)
Cindy Franklin, Peter Mohr, Leonie Bluhm, Friedegund Meier, Marlene Garzarolli, Michael Weichenthal, Katharina Kähler, Imke Grimmelmann, Ralf Gutzmer, Jochen Utikal, Patrick Terheyden, Rudolf Herbst, Sebastian Haferkamp, Claudia Pfoehler, Andrea Forschner, Ulrike Leiter, Fabian Ziller, Frank Meiss, Jens Ulrich, Alexander Kreuter, Christoffer Gebhardt, Julia Welzel, Bastian Schilling, Martin Kaatz, Karin Scharfetter-Kochanek, Edgar Dippel, Dorothee Nashan, Michael Sachse, Carsten Weishaupt, Harald Löffler, Thilo Gambichler, Carmen Loquai, Lucie Heinzerling, Stephan Grabbe, Dirk Debus, Gaston Schley, Jessica C Hassel, Gerhard Weyandt, Maike Trommer, Georg Lodde, Jan-Malte Placke, Lisa Zimmer, Elisabeth Livingstone, Jürgen Christian Becker, Susanne Horn, Dirk Schadendorf, Selma Ugurel
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 11 (4) (2023)
Cindy Franklin, Peter Mohr, Leonie Bluhm, Imke Grimmelmann, Ralf Gutzmer, Friedegund Meier, Marlene Garzarolli, Michael Weichenthal, Claudia Pfoehler, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Jens Ulrich, Dirk Debus, Sebastian Haferkamp, Martin Kaatz, Andrea Forschner, Ulrike Leiter, Dorothee Nashan, Alexander Kreuter, Michael Sachse, Julia Welzel, Lucie Heinzerling, Frank Meiss, Carsten Weishaupt, Thilo Gambichler, Gerhard Weyandt, Edgar Dippel, Kerstin Schatton, Eren Celik, Maike Trommer, Iris Helfrich, Alexander Roesch, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Susanne Horn, Selma Ugurel
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 10 (6) (2022)
Ines Pires daSilva, Tasnia Ahmed, Jennifer Leigh McQuade, Caroline A Nebhan, John J Park, Judith M Versluis, Patricio Serra-Bellver, Yasir Khan, Tim Slattery, Honey K Oberoi, Selma Ugurel, Lauren E Haydu, Rudolf Herbst, Jochen Utikal, Claudia Pföhler, Patrick Terheyden, Michael Weichenthal, Ralf Gutzmer, Peter Mohr, Rajat Rai, Jessica L Smith, Richard A Scolyer, Ana M Arance, Lisa Pickering, James M G Larkin, Paul C Lorigan, Christian U Blank, Dirk Schadendorf, Michael A Davies, Matteo S Carlino, Douglas B Johnson, Georgina V Long, Serigne N Lô, Alexander M Menzies
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Vincent Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe, Carmen Loquai
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers 14 (22) (2022)
Elias A T Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C Hassel, Sebastian Haferkamp, Katharina C Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus Vincent Heppt
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 14 (3) (2022)
Anne Zaremba, Philipp Jansen, Rajmohan Murali, Anand Mayakonda, Anna Riedel, Dieter Krahl, Hans Burkhardt, Stefan John, Cyrill Géraud, Manuel Philip, Julia Kretz, Inga Möller, Nadine Stadtler, Antje Sucker, Annette Paschen, Selma Ugurel, Lisa Zimmer, Elisabeth Livingstone, Susanne Horn, Christoph Plass, Dirk Schadendorf, Eva Hadaschik, Pavlo Lutsik, Klaus Georg Griewank
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions. Cancers 14 (17) (2022)
Valerie Glutsch, Patrick Schummer, Hermann Kneitz, Anja Gesierich, Matthias Goebeler, Detlef Klein, Christian Posch, Christoffer Gebhardt, Sebastian Haferkamp, Lisa Zimmer, Jürgen C Becker, Ulrike Leiter, Michael Weichenthal, Dirk Schadendorf, Selma Ugurel, Bastian Schilling
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 10 (11) (2022)
Ivelina Spassova, Selma Ugurel, Linda Kubat, Lisa Zimmer, Patrick Terheyden, Annalena Mohr, Hannah Björn Andtback, Lisa Villabona, Ulrike Leiter, Thomas Eigentler, Carmen Loquai, Jessica C Hassel, Thilo Gambichler, Sebastian Haferkamp, Peter Mohr, Claudia Pfoehler, Lucie Heinzerling, Ralf Gutzmer, Jochen S Utikal, Kai Horny, Hans-Ulrich Schildhaus, Daniel Habermann, Daniel Hoffmann, Dirk Schadendorf, Jürgen Christian Becker
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma. Journal for immunotherapy of cancer 10 (1) (2022)
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, Jan-Malte Placke, Eleftheria Chorti, Anne Zaremba, Georg Lodde, Philipp Jansen, Frederik Krefting, Julia Kretz, Inga Möller, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Lisa Zimmer, Selma Ugurel, Dirk Schadendorf, Eva Hadaschik, Klaus Georg Griewank
Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival. Cancers 14 (9) (2022)
Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Kurt Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Carsten Weishaupt, Julia Welzel, Michael Weichenthal
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7) (2022)
Dana Westphal, M Garzarolli, M Sergon, Peter Horak, Barbara Hutter, J C Becker, M Wiegel, E Maczey, Sophia Freya Ulrike Blum, S Grosche-Schlee, A Rütten, Selma Ugurel, Albrecht Stenzinger, Hanno Glimm, Daniela E Aust, G Baretton, Stefan Beissert, Stefan Fröhling, Silke Redler, Harald M Surowy, Friedegund Meier
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. The British journal of dermatology (2021)
Elias A T Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C Hassel, Sebastian Haferkamp, Bettina Hohberger, Katharina C Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus Vincent Heppt, null On Behalf Of The German Dermatologic Cooperative Oncology Group DeCOG Committee Ocular Melanoma
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis. Cancers 13 (13) (2021)
Ulrike Leiter, Carmen Loquai, Lydia Reinhardt, David Rafei-Shamsabadi, Ralf Gutzmer, Katharina Kaehler, Lucie Heinzerling, Jessica C Hassel, Valerie Glutsch, Judith Sirokay, Nora Schlecht, Albert Rübben, Thilo Gambichler, Kerstin Schatton, Claudia Pfoehler, Cindy Franklin, Patrick Terheyden, Sebastian Haferkamp, Peter Mohr, Lena Bischof, Elisabeth Livingstone, Lisa Zimmer, Michael Weichenthal, Dirk Schadendorf, Andreas Meiwes, Ulrike Keim, Claus Garbe, Jürgen Christian Becker, Selma Ugurel
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. Journal for immunotherapy of cancer 8 (2) (2021)
Sarah Knispel, Andreas Stang, Lisa Zimmer, Hildegard Lax, Ralf Gutzmer, Lucie Heinzerling, Carsten Weishaupt, Claudia Pföhler, Anja Gesierich, Rudolf Herbst, Katharina C Kaehler, Benjamin Weide, Carola Berking, Carmen Loquai, Jochen Utikal, Patrick Terheyden, Martin Kaatz, Max Schlaak, Alexander Kreuter, Jens Ulrich, Peter Mohr, Edgar Dippel, Elisabeth Livingstone, Jürgen Christian Becker, Michael Weichenthal, Eleftheria Chorti, Janine Gronewold, Dirk Schadendorf, Selma Ugurel
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG. Journal for immunotherapy of cancer 8 (1) (2021)
Lars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, Raluca-Ileana Mincu, Sebastian Korste, Simone Maria Mrotzek, Armin Spomer, Andrea Odersky, Christoph Rischpler, Ken Herrmann, Lale Umutlu, Cristina Coman, Robert Ahrends, Albert Sickmann, Stefanie Löffek, Elisabeth Livingstone, Selma Ugurel, Lisa Zimmer, Matthias Gunzer, Dirk Schadendorf, Matthias Totzeck, Tienush Rassaf
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy. European heart journal (2021)
Georg Lodde, Andrea Forschner, Jessica Hassel, Lena M Wulfken, Friedegund Meier, Peter Mohr, Katharina Kähler, Bastian Schilling, Carmen Loquai, Carola Berking, Svea Hüning, Kerstin Schatton, Christoffer Gebhardt, Julia Eckardt, Ralf Gutzmer, Lydia Reinhardt, Valerie Glutsch, Ulrike Nikfarjam, Michael Erdmann, Andreas Stang, Bernd Kowall, Alexander Roesch, Selma Ugurel, Lisa Zimmer, Dirk Schadendorf, Elisabeth Livingstone
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients. Cancers 13 (10) (2021)
Katharina C Kähler, Jessica C Hassel, Lucie Heinzerling, Carmen Loquai, Kai-Martin Thoms, Selma Ugurel, Lisa Zimmer, Ralf Gutzmer, null null
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 18 (6) (2020)